CD8A and neoplasm: A study found that a dose-dependent increase in the recruitment of Treg cells in a mouse model of breast cancer treated with PGE2 derived from tumor leads to increases in the cellular apoptosis of CD8+ T cells and promotes bone metastasis (97).